Arbutus Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
03 Apr 24 | BuyUS$15,961 | Whitefort Capital Management, LP | Company | 5,815 | US$2.74 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,557,067 | 0.822% |
Hedge Funds | 12,867,967 | 6.79% |
Public Companies | 38,847,462 | 20.5% |
General Public | 46,596,738 | 24.6% |
Institutions | 89,622,451 | 47.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
38,847,462 | US$132.5m | 0% | no data | |||
20,032,417 | US$68.3m | 3.22% | 0.05% | |||
12,867,967 | US$43.9m | 0% | 18.6% | |||
12,218,759 | US$41.7m | 5.77% | no data | |||
8,918,582 | US$30.4m | 27% | no data | |||
8,387,388 | US$28.6m | -2.15% | 4.35% | |||
4,407,133 | US$15.0m | 50.2% | no data | |||
3,448,600 | US$11.8m | 4.09% | no data | |||
2,972,527 | US$10.1m | 0% | 4.77% | |||
2,900,941 | US$9.9m | -3.3% | 0.02% | |||
2,089,321 | US$7.1m | -36.5% | 1.27% | |||
2,070,900 | US$7.1m | 0% | 3.16% | |||
1,681,090 | US$5.7m | 0% | 0.09% | |||
1,487,983 | US$5.1m | 0% | no data | |||
1,400,944 | US$4.8m | 9.13% | no data | |||
1,367,039 | US$4.7m | 0% | 0.04% | |||
1,362,454 | US$4.6m | 0.18% | 0.02% | |||
1,228,442 | US$4.2m | 16.9% | no data | |||
1,212,246 | US$4.1m | 219% | no data | |||
1,030,000 | US$3.5m | -38.9% | 0.03% | |||
853,304 | US$2.9m | 0% | 3.18% | |||
676,427 | US$2.3m | 3.84% | 0.05% | |||
668,153 | US$2.3m | -27.9% | 0.02% | |||
612,277 | US$2.1m | 0% | 0.07% | |||
607,744 | US$2.1m | 320% | no data |